Browse: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 1 | 3 |
Merck And Co., Inc patentsThe following is a sampling of recent Merck And Co., Inc patent applications (USPTO Patent Application #, Patent Title) sorted by month.
July 2009 - Merck And Co., Inc patents
20090176243 - Novel monkey gpr103 and monkey qrfp and method of evaluating compound by using gpr103
20090176263 - Canis sphingosine 1-phosphate receptort isoform 1
20090176757 - Bicyclic spirohydantoin cgrp receptor antagonists
20090176765 - Pyridinone and pyridazinone derivatives as inhibitors of poly (adp-ribose) polymerase (parp)
20090176789 - Diazaspirodecane orexin receptor antagonists
20090176836 - Cyclic ketal beta-secretase inhibitors for the treatment of alzheimer's disease
20090176854 - Pyrazole derivatives, compositions containing such compounds and methods of use
20090176859 - Cathepsin cysteine protease inhibitors
20090176861 - Cathepsin cysteine protease inhibitors
20090176986 - Process for the preparation of pyridine heterocycle cgrp antagonist intermediate
20090170159 - Production of glycoproteins with reduced o-glycosylation
20090170824 - Diarylsulfones as 5-ht2a antagonists
20090170828 - Azetidine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
20090170830 - Tricyclic beta-secretase inhibitors for the treatment of alzheimer's disease
20090170863 - Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
20090170891 - Niacin receptor agonists, compositions containing such compounds and methods of treatment
June 2009 - Merck And Co., Inc patents
20090162377 - Immunoglobulins comprising predominantly a gal2glcnac2man3glcnac2 glycoform
20090162377 - Immunoglobulins comprising predominantly a gal2glcnac2man3glcnac2 glycoform
20090163379 - Eukaryotic cell display systems
20090163379 - Eukaryotic cell display systems
20090163544 - Use of nk-3 receptor antagonists for the treatment of nausea and vomiting
20090163544 - Use of nk-3 receptor antagonists for the treatment of nausea and vomiting
20090163559 - Estrogen receptor modulators
20090163559 - Estrogen receptor modulators
20090155298 - Matrix metalloproteinase 11 vaccine
20090155847 - Combinatorial dna library for producing modified n-glycans in lower eukaryotes
20090156579 - Combination of a dipeptidyl peptidase-4 inhibitor and an anti-hypertensive agent for the treatment of diabetes and hypertension
20090156591 - Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors
20090156617 - Tyrosine kinase inhibitors
20090156619 - Heterocycle substituted amide and sulfur amide derivatives as histone deacetylase (hdac) inhibitors
20090156825 - Fluorescent compounds that bind to histone deacetylase
20090148850 - Methods for identifying modulators of p2ry14
20090149398 - 6,11-3c-bicyclic 8a-azalide derivatives
20090149467 - Tyrosine kinase inhibitors
20090149470 - Novel aminopyridine derivatives having aurora a selective inhibitory action
20090149526 - Tetracyclic indole derivatives as antiviral agents
20090143413 - Thiazole derivatives as cxcr3 receptor modulators
20090143429 - Quinoline derivatives as neurokinin receptor antagonists
May 2009 - Merck And Co., Inc patents
20090136449 - Tetracyclic indole derivatives as antiviral agents
20090136525 - Immunoglobulins comprising predominantly a glcnacman3glcnac2 glycoform
20090136570 - Taste-masked tablets and granules
20090136979 - Class iia histone deacetylase (hdac) substrate
20090137529 - Substituted esters as cannabinoid-1 receptor modulators
20090137546 - Anti-hypercholesterolemic compounds
20090137548 - 1,3-oxazolidin-2-one derivatives useful as cetp inhibitors
20090137576 - Novel piperidine derivative
20090137587 - Phenylpyridone derivative
20090130709 - Endomannosidases in the modification of glycoproteins in eukaryotes
20090131419 - Sulphones which modulate the action of gamma secretase
20090131423 - Tyrosine kinase inhibitors
20090131451 - Diagnosis and treatment of type 2 diabetes and other disorders
20090131464 - Spirochromanone derivatives as acetyl coenzyme a carboxylase (acc) inhibitors
20090131465 - Synthesis and crystalline forms of melanocortin-4 receptor agonist
20090131472 - P38 kinase inhibiting agents
20090131494 - Non-nucleoside reverse transcriptase inhibitors
20090131664 - Method for producing 4(3h)-quinazolinone derivative
20090123538 - Angiotensin ii receptor antagonists
20090123571 - Method of treating men with testosterone supplement and 5alpha-reductase inhibitor
20090124000 - Recombinant vectors
20090124600 - N-alkyl-azacycloalkyl nmda/nr2b antagonists
20090124601 - Tartaric acid salts of a dipeptidyl peptidase-iv inhibitor
20090124603 - Diazepan orexin receptor antagonists
20090124641 - Mitotic kinesin inhibitors
20090124648 - Synthesis and crystalline forms of npy5 antagonist
20090124661 - Hcv ns3 protease inhibitors
20090124665 - Potassium channel inhibitors
20090124689 - Cetp inhibitors
20090124799 - Process for the preparation of caprolactam cgrp antagonist
20090117590 - Human calcium sensitive potassium channel beta3 subunit proteins, encoding nucleic acid and uses thereof
20090117616 - Methods for reducing or eliminating alpha-mannosidase resistant glycans for the production of glycoproteins
20090118200 - Proline bis-amide orexin receptor antagonists
20090118223 - Novel 2'-c-methyl and 4'c-methyl nucleoside derivatives
20090118291 - Histone deacetylase inhibitors
20090118296 - Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
20090118300 - Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulators
20090118304 - 2-heteroaryl-substituted indole derivative
April 2009 - Merck And Co., Inc patents
20090111832 - Imidazolidinone compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
20090111997 - Method of generating amorphous solid for water-insoluble pharmaceuticals
20090104210 - Peptide compounds for treating obesity and insulin resistance
20090104210 - Peptide compounds for treating obesity and insulin resistance
20090104210 - Peptide compounds for treating obesity and insulin resistance
20090104220 - Method to make a peptide-carrier conjugate with a high immunogenicity
20090104220 - Method to make a peptide-carrier conjugate with a high immunogenicity
20090104220 - Method to make a peptide-carrier conjugate with a high immunogenicity
20090105136 - Npy y2 agonist for use as therapeutic agent for disease accompanied by diarrhea
20090105136 - Npy y2 agonist for use as therapeutic agent for disease accompanied by diarrhea
20090105136 - Npy y2 agonist for use as therapeutic agent for disease accompanied by diarrhea
20090105210 - Bicyclic pyrimidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
20090105210 - Bicyclic pyrimidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
20090105210 - Bicyclic pyrimidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
20090105219 - Spirolactam tricyclic cgrp receptor antagonists
20090105219 - Spirolactam tricyclic cgrp receptor antagonists
20090105219 - Spirolactam tricyclic cgrp receptor antagonists
20090105227 - Thienopyrroles as antiviral agents
20090105227 - Thienopyrroles as antiviral agents
20090105227 - Thienopyrroles as antiviral agents
20090105228 - Heterocyclic benzodiazepine cgrp receptor antagonists
20090105228 - Heterocyclic benzodiazepine cgrp receptor antagonists
20090105228 - Heterocyclic benzodiazepine cgrp receptor antagonists
20090105234 - Ep4 receptor agonist, compositions and methods thereof
20090105234 - Ep4 receptor agonist, compositions and methods thereof
20090105234 - Ep4 receptor agonist, compositions and methods thereof
20090105264 - Substituted nicotinamide compounds
20090105265 - Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with metformin
20090105264 - Substituted nicotinamide compounds
20090105265 - Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with metformin
20090105264 - Substituted nicotinamide compounds
20090105265 - Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with metformin
20090105270 - Kinase inhibition and anticancer therapy
20090105270 - Kinase inhibition and anticancer therapy
20090105270 - Kinase inhibition and anticancer therapy
20090105284 - Aminocyclohexanes as dipeptidyl peptidase-iv for the treatment or prevention of diabetes
20090105284 - Aminocyclohexanes as dipeptidyl peptidase-iv for the treatment or prevention of diabetes
20090105284 - Aminocyclohexanes as dipeptidyl peptidase-iv for the treatment or prevention of diabetes
20090105310 - Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
20090105310 - Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
20090105310 - Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
20090105318 - Amidoethylthioether orexin receptor antagonists
20090105318 - Amidoethylthioether orexin receptor antagonists
20090105318 - Amidoethylthioether orexin receptor antagonists
20090105321 - Indole amide derivatives as ep4 receptot ligands
20090105321 - Indole amide derivatives as ep4 receptot ligands
20090105321 - Indole amide derivatives as ep4 receptot ligands
20090105479 - 4-oxo-1-3-substituted phenyl-1,4-dihydro-1,8-napthyridene-3-carboxamide phosphodiesterase-4 inhibitor and a method of preparing same
20090105479 - 4-oxo-1-3-substituted phenyl-1,4-dihydro-1,8-napthyridene-3-carboxamide phosphodiesterase-4 inhibitor and a method of preparing same
20090105479 - 4-oxo-1-3-substituted phenyl-1,4-dihydro-1,8-napthyridene-3-carboxamide phosphodiesterase-4 inhibitor and a method of preparing same
20090098155 - Peptide conjugate compositions and methods for the prevention and treatment of alzheimer's disease
20090098604 - Synthetic gene encoding human epidermal growth factor 2/neu antigen and uses thereof
20090099126 - Ribonucleoside cyclic acetal derivatives for the treatment of rna-dependent rna viral infection
20090099168 - Hiv integrase inhibitors
20090099200 - Azacyclohexane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
20090099226 - Quinoline derivatives as ep4 antagonists
20090099264 - Fluoroalkylamine derivatives as cathepsin inhibtors
20090092971 - Method for detecting p53 dysfunction, method for molecular diagnosis of cancer and method for evaluating compound effective in treating cancer
20090093020 - Methods for reducing or eliminating alpha-mannosidase resistant glycans in the production of glycoproteins
20090093444 - Cathepsin cysteine protease inhibitors
20090093527 - Azacyclopentane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
20090093552 - Addition of lecithin as an antistatic agent for the crystallization processing of organic molecules
20090088431 - Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
20090088431 - Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
20090088436 - P38 kinase inhibiting agents
20090088436 - P38 kinase inhibiting agents
20090088452 - Indole orexin receptor antagonists
20090088452 - Indole orexin receptor antagonists
20090088458 - N-(pyridin-4-yl)-2-phenylbutanamides as androgen receptor modulators
20090088458 - N-(pyridin-4-yl)-2-phenylbutanamides as androgen receptor modulators
20090088477 - Compounds and methods for leukotriene biosynthesis inhibition
20090088477 - Compounds and methods for leukotriene biosynthesis inhibition
20090089889 - Neuromedin u receptor subtype 1 deficient transgenic mice and uses thereof
20090089889 - Neuromedin u receptor subtype 1 deficient transgenic mice and uses thereof
March 2009 - Merck And Co., Inc patents
20090081645 - Method of assuming drug sensitivity to cdk4 inhibitor
20090081681 - Method for genetic selection of high-plasmid producing e. coli clones
20090082221 - Cross-species and multi-species display systems
20090082308 - Benzothiophene derivatives
20090082320 - Fluorinated 4-azasteroid derivatives as androgen receptor modulators
20090074890 - Substituted triazoles as sodium channel blockers
20090075319 - Method of detecting reactive metabolite
20090075869 - Hcv ns3 protease inhibitors
20090075979 - Cetp inhibitors
20090075998 - 2-(phenyl or heterocyclic)-1h-phenantrho[9,10-d]imidazoles as mpges-1 inhibitors
20090076101 - Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors
20090068678 - Method for identifying modulators of noah10 useful for treating alzheimer's disease
20090069250 - Inhibitors of histone deacetylase
20090069283 - Potassium channel inhibitors
20090069284 - Substituted 3-alkyl and 3-alkenyl azetidine derivatives
20090069312 - Potassium channel inhibitors
20090069344 - Modulators of hcv replication
20090069376 - Vla-4 antagonists
20090069385 - Antidiabetic oxazolidinediones and thiazolidinediones
20090069391 - Benzothiophene hydroxamic acid derivatives
20090062269 - Niacin receptor agonists, compositions containing such compounds and methods of treatment
20090062280 - Ophthalmic compositions for treating ocular hypertension
20090062293 - 1,4-substituted piperazine derivatives
20090062297 - Hydroxyalkylarylamide derivatives
20090062302 - Jak2 tyrosine kinase inhibition
20090062327 - Inhibitors of akt activity
20090062349 - 1-hydroxycycloalkanecarboxamide derivatives
February 2009 - Merck And Co., Inc patents
20090054399 - Hiv integrase inhibitors
20090054408 - Monocyclic anilide spirolactam cgrp receptor antagonists
20090054423 - Niacin receptor agonists, compositions containing such compounds and methods of treatment
20090054440 - Quinoline derivatives as neurokinin receptor antagonists
20090054448 - Amino acid derivatives as histone deacetylase (hdac) inhibitors
20090054462 - Hydroisoindoline tachykinin receptor antagonists
20090054483 - Substituted quinolines as inhibitors of leukotriene biosynthesis
20090054506 - Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
20090054662 - Process for synthesizing a substituted pyrazole
20090047303 - Method for improving the immunogenicity of plasmodium antigens
20090047702 - Method for identifying modulators of keah6 useful for treating alzheimer's disease
20090048227 - Substituted-1-phthalazinamines as vr- 1 antagonists
20090048228 - Heterocycle derivatives as histone deacetylase (hdac) inhibitors
20090048239 - Therapeutic compounds
20090048248 - Octahydropyrano[3,4-c]pyrrole tachykinin receptor antagonists
20090048276 - Inhibitors of fatty acid synthase (fas)
20090048283 - Salt of an androgen receptor modulator
20090048308 - Vla-4 antagonists
20090042854 - Hexahydro-3h-pyrrolizin-3-ones useful as tachykinin receptor antagonists
20090042892 - Cetp inhibitors
20090042926 - Niacin receptor agonists, compositions containing such compounds and methods of treatment
20090042944 - Potassium channel inhibitors
20090042954 - 2-(aryl)azacyclylmethyl carboxylates, sulfonates, phosphonates, phosphinates and heterocycles as s1p receptor antagonists
20090042966 - Mitotic kinesin inhibitors
20090035277 - Hepatitis c virus nucleic acid vaccine
20090036443 - Thienopyrroles as antiviral agents
20090036503 - Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
January 2009 - Merck And Co., Inc patents
20090029406 - Npy y4 agonist as therapeutic agent for disease accompanied by intestinal tract dysfunction
20090030012 - Pyridine, pyrimidine and pyrazine derivatives as cxcr3 receptor modulators
20090030043 - Potassium channel inhibitors
20090030048 - Novel pharmaceutical compounds
20090023163 - Method of measuring enzyme activity and method of evaluating compound
20090023767 - Inhibitors of checkpoint kinases
20090023774 - Pyridine analogs as c5a antagonists
20090025095 - Method for evaluating compound using barlp and substance for regulating eating and body weight
20090017468 - Method of screening compound directly activating glycogen synthase
20090018054 - Cholesteryl ester transfer protein inhibitors
20090018056 - Heteroarylcarbamoylbenzene derivatives
20090018340 - Formation of tetra-substituted enamides and stereoselective reduction thereof
20090012061 - A method of treating cancer
20090012075 - Fluorinated arylamide derivatives
20090012076 - Tyrosine kinase inhibitors
20090012134 - Arylsulfonyl benzofused heterocycles as 5-ht2a antagonists
20090005323 - Cathepsin k inhibitors and obesity
20090005389 - 2,5 diaza-bicyclo [2.2.1] heptane derivatives as calcium channel blockers
20090005418 - Mitotic kinesin inhibitors
20090007283 - Transgenic rodents selectively expressing human b1 bradykinin receptor protein
October 2008 - Merck And Co., Inc patents
20080261938 - Tetracyclic indole derivatives as antiviral agents
20080261944 - Indole derivatives as antiviral agents
20080261972 - Cgrp receptor antagonists
20080262035 - Amide derivatives as inhibitors of histone deacetylase
20080262046 - Amidopropoxyphenyl orexin receptor antagonists
20080262051 - Triazole derivatives which are smo antagonists
20080254059 - Adenovirus serotype 26 vectors, nucleic acid and viruses produced thereby
20080255072 - Composition for inhibition of cathepsin k
20080255216 - Diaryltriazoles as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
20080248040 - Nucleic acid molecules encoding novel human low-voltage activated calcium channel proteins, designed-alpha 1i-1 and alpha 1i-2, encoded proteins and methods of use thereof
20080248062 - Papillomavirus vaccine compositions
20080249093 - (3,4-disubstituted)propanoic carboxylates as sip (edg) receptor agonists
20080249146 - Imidazole and thioazole derivatives as antiviral agents
20080242597 - Antibiotic compounds
20080242643 - Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
20080242657 - Treatment of tremor with histamine h3 inverse agonists or hist amine h3 antagonists
20080242722 - Combination therapy for treating cyclooxygenase-2 mediated diseases or conditions in patients at risk of thrombotic cardiovascular events
September 2008 - Merck And Co., Inc patents
20080234281 - Mitotic kinesin inhibitors
20080226660 - Optimized expression of hpv 58 l1 in yeast
20080227758 - Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
20080227778 - Isoquinolinone potassium channel inhibitors
20080227786 - Novel crystalline salts of a dipeptidyl peptidase-iv inhibitor
20080221157 - Amide derivatives as inhibitors of histone deacetylase
20080221198 - Novel crystalline forms of antidiabetic compounds
20080214511 - Tricyclic anilide spirolactam cgrp receptor antagonists
20080214522 - Antiviral indoles
20080214594 - Inhibitors of checkpoint kinases
August 2008 - Merck And Co., Inc patents
20080206786 - Trace amine receptor 1 of the african green monkey
20080207666 - Substituted pyrano[2,3-b]pyridine derivatives as cannabinoid-1 receptor modulators
20080207693 - Mitotic kinesin inhibitors
20080199459 - Mitotic kinesin inhibitors
20080199942 - Method of engineering a cytidine monophosphate-sialic acid synthetic pathway in fungi and yeast
20080200376 - Compositions and methods for the treatment of obesity and sexual dysfunction
20080200494 - Imidazopyridine derivatives
20080200513 - Pyridine n-oxides as antiviral agents
20080193445 - Novel anti-igf-ir antibodies and uses thereof
20080193449 - Antibodies specific for dkk-1
20080193950 - Assay for cytochrome p450 isoform 2c9
20080194548 - Drug combination therapy and pharmaceutical compositions for treating inflammatory disorders
20080194582 - Mitotic kinesin inhibitors
20080194586 - Fused-aromatic compounds having anti-diabetic activity
20080194645 - Substituted amides
20080187903 - Hcv rna-dependent rna polymerase
20080188521 - Novel pharmaceutical compounds
20080188529 - Cathepsin cysteine protease inhibitors
July 2008 - Merck And Co., Inc patents
20080182838 - Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
20080182843 - Mitotic kinesin inhibitors
20080176869 - Tetrahydro-4h-pyrido[1,2-a] pyrimidines useful as hiv integrase inhibitors
20080176904 - Benzazole potentiators of metabotropic glutatmate receptors
20080171692 - Substituted amides
20080171753 - Carbamoyl-substituted spiro derivative
20080171761 - Substituted spirochromanone derivatives
20080171777 - Biaryl substituted triazoles as sodium channel blockers
20080171888 - Process for making spirolactone compounds
20080172752 - Neuromedin u receptor subtype 1 deficient transgenic mice and uses thereof
20080166371 - Optimized expression of hpv 31 l1 in yeast
20080167322 - Substituted pyrazoles as modulators of chemokine receptors
20080167329 - Quinazolinone t-type calcium channel antagonists
20080167345 - Amide substituted indazoles as poly(adp-ribose)polymerase(parp) inhibitors
20080161317 - Inhibitors of akt activity
20080161326 - Novel sulfone amide amide derivatives
20080161347 - Substituted aryl and heteroaryl derivatives, compositions containing such compounds and methods of use
20080161363 - 2-aminopyridine compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
20080161372 - Methods for the treatment of hypertension
June 2008 - Merck And Co., Inc patents
20080153817 - Treatment for alzheimer's disease and related conditions
20080153846 - Aminomethyl beta-secretase inhibitors for the treatment of alzheimer's disease
20080153851 - Cycloalkyl piperidine tachykinin receptor antagonists
20080153887 - Mitotic kinesin inhibitors
20080153893 - Pyrazole carboxamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
20080153895 - Antiviral indoles
20080145430 - Ophthalmic nanoparticulate formulation of a cyclooxygenase-2 selective inhibitor
20080145886 - Assay for cytochrome p450 isoforms 3a4 and 3a5
20080146588 - Piperidinyl piperidine tachykinin receptor antagonists
20080138361 - Optimized expression of hpv 45 l1 in yeast
20080138866 - Process for the preparation of (r)-4,4-dialkoxy-pyran-3-ols such as (r)-4,4-dimethoxy-pyran-3-ol
20080138886 - Upstream and a downstream purification process for large scale production of plasmid dna
20080139470 - Erythropoietin compositions
20080139538 - Tertiary carbinamines having substituted heterocycles which are active as beta-secretase inhibitors for the treatment of alzheimer's disease
20080139578 - Substituted piperizines for the treatment of pain
20080139579 - Hiv integrase inhibitors
20080139586 - Mitotic kinesin inhibitors
20080139589 - Crystal of 4(3h)-quinazolinone derivative
20080139596 - Modulators of hcv replication
20080139604 - Method of treating atherosclerosis, dyslipidemias and related conditions
20080139614 - Treatment of stroke with histamine h3 inverse agonists or histamine h3 antagonists
20080139630 - N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
20080131447 - Polypeptides for inducing a protective immune response against staphylococcus aureus
20080131516 - Granule formation
20080132488 - Prodrugs of (2r)-2-propyloctanoic acid for the treatment of stroke
20080132490 - Substituted diazepan orexin receptor antagonists
20080132500 - Antibiotic compounds
20080132542 - Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
20080132575 - Formulations of suberoylanilide hydroxamic acid and methods for producing same
May 2008 - Merck And Co., Inc patents
20080124402 - N-(pyridin-3-yl)-2-phenylbutanamides as androgen receptor modulators
20080125399 - 17 beta-acetamide-4-azasteroids as androgen receptor modulators
20080125403 - Method of treating men with metabolic and anthropometric disorders
20080125413 - Cgrp receptor antagonists
20080125429 - Aryloxy-substituted benzimidazole derivatives
20080125442 - Cathepsin k inhibitors and atherosclerosis
20080118436 - Pathological animal model for non-alcoholic fatty hepatitis
20080118559 - Pharmaceutical composition containing an anti-nucleating agent
20080118970 - Methods of adenovirus purification
20080119476 - Cetp inhibitors
20080119503 - Androgen receptor modulators and methods of use thereof
20080119509 - Altenrative forms of the phosphodeisterase -4 inhibitor n-cyclopropyl-1- -3{3-[(1-oxidopyryidin-3-yl) phenyl]-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxyamide
20080119531 - Indoles having anti-diabetic activity
20080113927 - Indolopyrrolocarbazole derivatives and anti-tumor agent
20080113966 - Cgrp receptor antagonists
20080114016 - Inhibitors of checkpoint kinases
20080115235 - Drugs for diseases accompanying changes in total bile acid pool or lipid metabolism disorders and method of screening these drugs
20080108620 - Substituted pyrazoles, compositions containing such compounds and methods of use
20080108663 - Cyclopropyl piperidine glycine transporter inhibitors
20080108689 - Octahydropyrano[3,4-c]pyrrole tachykinin receptor antagonists
20080108823 - Method for producing thioether compound
20080102068 - Mitotic kinesin inhibitors
20080103136 - Novel fused imidazole derivative
20080103178 - N-dihydroxyalkyl-substituted 2-oxo-imidazole derivatives
April 2008 - Merck And Co., Inc patents
20080095792 - Polypeptides for inducing a protective immune response against staphylococcus aureus
20080095850 - Process for granulating particles
20080096856 - Antibiotic compound
20080096859 - Compositions and methods for treating ophthalmic diseases
20080096878 - Bicyclic anilide spirolactam cgrp receptor antagonists
20080096885 - Quinoline derivatives as neurokinin receptor antagonists
20080096920 - Histone deacetylase inhibitors
20080096927 - Combination therapy for treating cyclooxygenase-2 mediated diseases or conditions in patients at risk of thrombotic cardiovascular events
20080096935 - Heterocyclic indanone potentiators of metabotropic glutamate receptors
20080097108 - Ophthalmic compositions for treating ocular hypertension
20080090274 - Process for the synthesis of (s)-1-(3,5-bis (trifluoromethyl)-phenyl-ethan-1-ol
20080090778 - Telomerase reverse transcriptase fusion protein, nucleotides encoding it, and uses thereof
20080090794 - Potassium channel inhibitors
20080090796 - Piperidine and azetidine derivatives as glyt1 inhibitors
20080090799 - 2-pyridinecarboxamide derivative having gk-activating effect
20080090806 - Cgrp receptor antagonists
20080090865 - Antidiabetic bicyclic compounds
20080085540 - Method of engineering a cytidine monophosphate-sialic acid synthetic pathway in fungi and yeast
20080085885 - Inhibition of voluntary ethanol consumption with non-peptidyl melanocortin-4 receptor agonists
20080085926 - Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
20080086006 - Process for making substituted piperidines
20080081803 - Heterocyclic cyclopentyl tetrahydroisoquinoline and tetrahydropyridopyridine modulators of chemokine receptor activity
20080081811 - Selective inhibitors against cdk4 and cdk6 having aminothiazole skeleton
March 2008 - Merck And Co., Inc patents
20080076773 - Aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
20080076783 - Cycloalkyl keto piperidine tachykinin receptor antagonists
20080076795 - 1h-benzo[f]indazol-5-yl derivatives as selective glucocorticoid receptor modulators
20080076805 - Acyclic hydrazides as cannabinoid receptor modulators
20080076810 - Benzoureas having anti-diabetic activity
20080070894 - Novel substituted imidazole derivative
20080070895 - Heteroaryl substituted spirocyclic sulfamides for inhibition of gamma secretase
20080070899 - Cgrp receptor antagonists
20080070928 - Novel 2-heteroaryl-substituted benzimidazole derivative
20080070940 - 4-oxo-1-(3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitor and a method of preparing same
20080063656 - Adenoviral vector compositions
20080064632 - Combination therapy for the treatment of obesity
20080057529 - Method for identifying histone deacetylase inhibitors
20080058347 - Novel aminopyridine derivatives having aurora a selective inhibitory action
20080058522 - Process for the preparation of enantiomerically enriched beta amino acid derivatives
February 2008 - Merck And Co., Inc patents
20080051403 - Treatment for alzheimer's disease and related conditions
20080051430 - Acylated piperidine derivatives as melanocortin 4-receptor agonists
20080045492 - Mitotic kinesin inhibitors
20080045515 - Cyclic sulfonamides for inhibition of gamma-secretase
20080045533 - Novel cyclohexyl sulphones
20080039494 - 8-phenyl-5,6,7,8-hydroquinoline tachykinin receptor antagonists
20080039514 - Compounds for the treatment of dyslipidemia and other lipid disorders
20080032951 - Ophthalmic compositions for treating ocular hypertension
20080032959 - Estrogen receptor modulators
20080032980 - Mitotic kinesin inhibitors
20080032996 - Substituted quinazoline or pyridopyrimidine derivative
20080033015 - Histone deacetylase inhibitors
20080033028 - Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment
January 2008 - Merck And Co., Inc patents
20080027042 - Novel aminopyridine derivatives having aurora a selective inhibitory action
20080027058 - Mitotic kinesin inhibitors
20080027093 - Cyclohexylalanine derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
20080027095 - Use of 3-substituted-2-(diphenylmethy)-1-azabicyclo[2.2.2]octanes for treating mrg-x1 receptor mediated diseases
20080027118 - Prodrugs of mitotic kinesin inhibitors
20080021001 - Methods for treating arthritic conditions in dogs
20080021009 - 1,2,4-oxadiazole derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
20080021010 - Azetidine glycine transporter inhibitors
20080021043 - Piperidines and related compounds for treatment of alzheimer's disease
20080021047 - C-purine nucleoside analogs as inhibitors of rna-dependent rna viral polymerase
20080021057 - 3,3-disubstituted tetrahydropyranyl cyclopentyl amide modulators of chemokine receptor activity
20080021061 - Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity
20080021067 - Methods for the treatment of substance abuse and addiction
20080015173 - Estrogen receptor modulators
20080015187 - Hiv integrase inhibitors
20080015190 - Inhibitors of histone deacetylase
20080015212 - Inhibitors of akt activity
20080015213 - Macrocyclic aminopyridyl beta-secretase inhibitors for the treatment of alzheimer's disease
20080015216 - Histone deacetylase inhibitors
20080015233 - 2,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
20080008708 - Tyrosine kinase inhibitors
20080009016 - Novel monkey gpr103 and monkey qrfp and method of evaluating compound by using gpr103
20080009490 - Hiv integrase inhibitors
20080009507 - Inhibitors of akt activity
20080009510 - Fused aminopiperidine as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
20080009518 - 5-phenyl-5,6,7,8-hydroquinoline tachykinin receptor antagonists
20080004259 - Inhibitors of checkpoint kinases
20080004304 - Aryl spirolactam cgrp receptor antagonists
December 2007 - Merck And Co., Inc patents
20070298099 - Liquid and semi-solid pharmaceutical formulations for oral administration of a substituted amide
20070298498 - Adenoviral amplicon and producer cells for the production of replication-defective adenoviral vectors, methods of preparation and use thereof
20070299048 - Combination of gaboxadol and 5ht2 antagonists
20070299070 - 2-arylcarboxamide-nitrogenous heterocycle compound
20070299101 - Niacin receptor agonists, compositions containing such compounds and methods of treatment
20070299104 - Tetrahydropyranyl cyclopentyl 1-substituted and 1,1-disubstituted tetrahydroisoquinoline modulators of chemokine receptor activity
20070299122 - Method of treating pathological blushing
20070292504 - Pharmaceutical formulation containing a release rate controlling composition
20070292895 - Assays and methods to detect beta-secretase and its activity in body fluids and tissue extracts
20070293470 - Carboxamide spirolactam cgrp receptor antagonists
20070293492 - Quinoline tachykinin receptor antagonists
20070293497 - 2,3,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
20070293515 - 1,3-disubstituted heteroaryl nmda/nr2b antagonists
20070293558 - Ophthalmic compositions for treating ocular hypertension
20070293578 - Cathepsin cysteine protease inhibitors
20070293706 - Synthesis of 1,5-disubstituted-2-hydroxy-gibbatetraen-6-ones
20070287696 - Cgrp receptor antagonists
20070287697 - Cgrp receptor antagonists
20070287716 - Pyrimidine and quinoline potentiators of metabotropic glutamate receptors
20070287736 - Diphenyl substituted alkanes as flap inhibitors
20070281941 - Amorphous form of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor
20070281952 - Arylsulfonylnaphthalene derivatives as 5ht2a antagonists
20070281969 - Niacin receptor agonists, compositions containing such compounds and methods of treatment
November 2007 - Merck And Co., Inc patents
20070274916 - Method for identifying compounds that affect expression of tryptophan hydroxylase isoform 2
20070275379 - Simian orl1 gene and method of assessing compound
20070275912 - Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
20070269405 - Androgen receptor modulators
20070264278 - Polypeptides for inducing a protective immune response against staphylococcus aureus
20070264674 - Cytochrome p450 induction assay
20070265225 - Substituted monocyclic cgrp receptor antagonists
20070265222 - Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection
20070265318 - Estrogen receptor modulators
20070265332 - Antidiabetic bicyclic compounds
20070265442 - Process for {3-[2(r)-[(1r)-1-[3,5-bis (trifluoromethyl) phenyl]ethoxy]-3(s)-(4-fluorophenyl) morpholin-4-yl}-5-oxo-4,5-dihydro-[1,2,4]-triazol-1-yl}phosphonic acid
20070259894 - Use of atazanavir for improving the pharmacokinetics of drugs metabolized by ugt1a1
20070259912 - Polymorphic forms of a gabaa agonist
20070259959 - Ppar agonists for the treatment of hcv infection
20070254865 - Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
20070254879 - Inhibitors of checkpoint kinases
20070254880 - Heteroaryl piperidine glycine transporter inhibitors
20070254892 - Dihydropyrazolopyrimidinone derivatives
20070254901 - Inhibitors of akt activity
20070254958 - Phenyl carboxamide compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
October 2007 - Merck And Co., Inc patents
20070248613 - Human antibodies interacting with hiv gp41
20070249606 - Morpholinyl piperidine glycine transporter inhibitors
20070249659 - Imidazopyridine compound
20070243205 - Polypeptides for inducing a protective immune response against staphylococcus aureus
20070243266 - Fluorinated 4-azasteroids as androgen receptor modulators
20070244048 - Neuromedin u receptor agonists and uses thereof
20070244055 - Conjugates useful in the treatment of prostate cancer
20070244107 - Method of treating atherosclerosis, dyslipidemias and related conditions
20070244119 - 1,3,5-substituted phenyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
20070244297 - Human calcium channel compositions and methods
20070244329 - Enantioselective synthesis of 13-oxotricyclo[8.2.1.0. 3,8] trideca-3(8),4,6-triene-5-carboxylates
20070238723 - Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors
20070231874 - Crystal of glucokinase protein, and method for drug design using the crystal
20070232676 - Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
20070232678 - (4, 5, 6, 7-tetrahydro-1-h-indol-7-yl) acetic acid derivatives for treatment of alzheimer's disease
September 2007 - Merck And Co., Inc patents
20070224212 - Stable peptide mimetic of hiv gp41 fusion intermediate
20070224263 - Aminoalkylphosphonates and related compounds as edg receptor agonists
20070225229 - N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
20070225272 - Cgrp receptor antagonists
20070225365 - Cetp inhibitors
20070225499 - Process for the preparation of 2,2-disubstituted pyrroles
20070225520 - Stereoselective synthesis of a 4,4-disubstituted cyclohexanepropanoic acid
20070219252 - Vla-r antagonists
20070219354 - Assays using amyloid precursor proteins with modified beta-secretase cleavage sites to monitor beta-secretase activity
20070219382 - Process for making n-sulfonated-amino acid derivatives
20070213329 - Sulphones which modulate the action of gammasecretase
20070213332 - Prodrugs of substituted amino heterobicycles which modulate the function of the vanilloid-1 receptor (vr1)
20070213338 - Triazolo-pyridazine compounds and derivatives thereof useful in the treatment of neuropathic pain
20070208010 - Fused triazole derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
20070208017 - 2-(phenyl or heterocyclic)-1h-phenantrho[9,10-d]imidazoles as mpges-1 inhibitors
20070208046 - Pyridone derivative
August 2007 - Merck And Co., Inc patents
20070202547 - Methods for detecting substances which bind to the amyloid precursor protein or beta amyloid fragments, and binding compounds
20070203102 - Estrogen receptor modulators
20070203119 - Combination therapy for the treatment of schizophrenia
20070203147 - 2-aminothiazole compounds useful as aspartyl protease inhibitors
20070203186 - Pyrazole amide derivatives, compositions containing such compounds and methods of use
20070203205 - Diarylsulfones as 5-ht2a antagonists
20070197571 - Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of alzheimer' s disease
20070197585 - Use of cysteinyl leukotriene 2 receptor antagonists
20070197796 - Process for producing indolopyrrolocarbazole derivative
20070189865 - Amino cyclopropane carboxamide derivatives as bradykinin antagonists
20070191389 - Biaryl derivatives
20070191419 - Cycloalkanopyridine derivative
20070191433 - Acylated piperidine derivatives as melanocortin 4-receptor agonists
20070191438 - Methods for the treatment of hypertension
20070184488 - Beta-secretase substrates and uses thereof
20070185313 - Human neuronal nicotinic acetylcholine receptor compositions and methods employing same
20070178462 - Nucleic acid molecules encoding novel murine low-voltage activated calcium channel proteins, designated-alpha1h, encoded proteins and methods of use thereof
20070178551 - Methods for producing modified glycoproteins
20070179158 - 2,6-disubstituted piperiddines as modulators
20070179190 - Vla-4 antagonists
20070179196 - Hiv integrase inhibitors
July 2007 - Merck And Co., Inc patents
20070172498 - Polypeptides for inducing a protective immune response against staphyloococcus aureus
20070173434 - Antidiabetic oxazolidinediones and thiazolidinediones
20070173507 - Dairyl-substituted five-membered heterocycle derivative
20070173525 - Tyrosine kinase inhibitors
20070167447 - Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase
20070167453 - Nitrogenous fused heteroaromatic ring derivative
20070167635 - Cathepsin cysteine protease inhibitors
20070161542 - Ptb1b photoprobes
20070161639 - Hiv integrase inhibitors
20070161689 - Indoles having anti-diabetic activity
20070161695 - Hydroisoindoline tachykinin receptor antagonists
20070155660 - Inhibition of voluntary ethanol consumption with selective melanocortin 4-receptor agonists
20070155731 - Aminocyclopentyl pyridopyrazinone modulators of chemokine receptor activity
20070155744 - N-benzyl-3,4-dihyroxypyridine-2-carboxamide and n-benzyl-2,3-dihydroxypyridine-4- carboxamide compounds useful as hiv integrase inhibitors
June 2007 - Merck And Co., Inc patents
20070148188 - Anthrax vaccine
20070148765 - Preservative-containing virus formulations
20070149529 - Amino heterocyclic modulators of chemokine receptor activity
20070149536 - Inhibitors of akt activity
20070149547 - Bipyridyl amides as modulators of metabotropic glutamate receptor-5
20070149553 - Mitotic kinesin inhibitors
20070149568 - N-substituted nonaryl-heterocyclic nmda/nr2b antagonists
20070149579 - Novel pharmaceutical compounds
20070149761 - Hcv rna dependent rna polymerase
20070141636 - Method for identifying androgen receptor modulators with full or mixed agonist activity
20070142388 - Inhibitors of akt activity
20070142453 - 1-alkyl-3-thio-substituted indole-2-alkynoic acids useful for the treatment of alzheimer's disease and related conditions
20070142634 - Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of alzheimer's disease
20070142635 - Process for preparing hexahydropyrimido[1,2-a]azepine-2-carboxylates and related compounds
20070134157 - Biological assay
20070134263 - Polypeptides for inducing a protective immune response against staphyloococcus aureus
20070135357 - Anti-hypercholesterolemic compounds
20070135423 - E-fluoro-4-(pyridin-2-yl)-piperidine-1-carboxamide derivatives and related compounds which modulate the function of the vanilloid-1 receptor (vr1) for the treatment of pain
20070135454 - Bicyclic pyrimidin-4(3h)-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1-receptor(vr1)
20070135474 - Ccr-2 antagonist salt
20070135475 - Process for the preparation of ccr-2 antagonists
20070129309 - Conjugates useful in the treatment of prostate cancer
20070129356 - Mitotic kinesin inhibitors
20070129372 - P38 kinase inhibiting agents
20070129374 - Indazol-3-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1 receptor (vr1)
20070129418 - Ophthalmic compositions for treating ocular hypertension
20070129548 - Polymorphs of an androgen receptor modulator
May 2007 - Merck And Co., Inc patents
20070122849 - Rhesus monkey p2x7 purinergic receptor and uses thereof
20070123470 - Enhancement of growth hormone levels with a dipeptidyl peptidase iv inhibitor and a growth hormone secretagogue
20070123505 - Heterocycle-substituted 3-alkyl azetidine derivatives
20070123524 - N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase
20070123587 - Prodrugs of diaryl-2-(5h)-furanone cyclooxygenase-2 inhibitors
20070117797 - Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity
20070117824 - Spirocyclic compounds
20070117847 - N-(3-(4-substituted-1-piperiding1)-1-phenylpropyl) substituted sulfonamides as nk-3 receptor antagonists
20070111253 - Rhesus monkey dickkopf-1, nucleotides encoding same, and uses thereof
20070111957 - Synthetic gene encoding human epidermal growth factor 2/neu antigen and uses thereof
20070111982 - Carboxamide spirohydantoin cgrp receptor antagonists
20070104685 - Synthetic gene encoding human carcinoembryonic antigen and uses thereof
20070105091 - Real time assay for rotavirus
20070105127 - Method for producing modified glycoproteins
20070105827 - Estrogen receptor modulators
20070105901 - Novel piperidine derivative
20070105902 - 4-phenyl piperdine sulfonyl glycine transporter inhibitors
20070105914 - Substituted sulfonamides
20070105930 - Cyclic guanidines, compositions containing such compounds and methods of use
20070098636 - Method of identifying responders to treatment with insulin sensitizers
20070099880 - Estrogen receptor modulators
20070099884 - Combination therapy for the treatment of diabetes
20070099893 - Cathepsin cysteine protease inhibitors
20070099926 - Combination therapy for treating chronic inflammatory diseases
20070099950 - Pyridin-4-ylamine compounds useful in the treatment of neuropathic pain
20070099951 - 4-oxo-1-(3-substituted phenyl)-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitor and a method of preparing same
20070101449 - Transgenic animal having an amyloid precursor protein with a modified beta secretase cleavage site
April 2007 - Merck And Co., Inc patents
20070092526 - Polynucleotide vaccine adjuvants and formulations containing cationic surfactants, and methods of use
20070092961 - Process to cultivate brevundimonas diminuta for filtration validation
20070093496 - Hydroxy pyridopyrrolopyrazine dione compounds useful as hiv integrase inhibitors
20070093544 - Benzamidazoles, compositions containing such compounds and methods of use
20070087052 - Effervescent bisphosphonate formulation
20070087346 - Orthogonal gene switches
20070087384 - Cynomolgus monkey dickkope-4, nucleotides encoding same, and uses thereof
20070088028 - 17-acetamido-4-azasteroid derivatives as androgen receptor modulators
20070088042 - Fluorinated 4-azasteroid derivatives as androgen receptor modulators
20070088047 - 21-heterocyclic-4-azasteroid derivatives as androgen receptor modulators
20070088058 - Aralkyl amines as cannabinoid receptor modulators
20070088063 - Gamma-secretase inhibitors
20070088070 - Pyrazole derivatives, compositions containing such compounds and methods of use
20070088071 - Acyl indoles, compositions containing such compounds and methods of use
20070088165 - Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
20070082067 - Di-aryl substituted triazole modulators of metabotropic glutamate receptor-5
20070082906 - Inhibitors of akt activity
20070083037 - Monkey npy y4 receptor and method of evaluating compound
20070083045 - Dihydroxypyrimidine carboxamide inhibitors of hiv integrase
20070077257 - Enhanced first generation adenovirus vaccines expressing condon optimized hiv1-gag, pol, nef and modifications
20070077642 - Steroid receptor modulation of gene expression
20070078098 - Anti-hypercholesterolemic compounds
20070078154 - Quinoline potassium channel inhibitors
20070078156 - Derivatives of n-(1h-indazolyl)-and n-(1h-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (vr1) for treatment of pain
March 2007 - Merck And Co., Inc patents
20070048320 - Method for indentifying modulators of ppil2 useful for treating alzheimer's disease
February 2007 - Merck And Co., Inc patents
20070042343 - Forward mutation assay based on 5-fluorouracil resistance
20070042975 - Novel indolopyrrolocarbazole derivative with antitumor activity
20070043001 - Inhibitors of akt activity
20070043015 - Phenyl pyrrolidine ether tachykinin receptor antagonists
20070043014 - 3,5-aryl, heteroaryl or cycloalkyl substituted-1,2,4-oxadiazoles as s1p receptor agonists
20070043042 - Quinoline potassium channel inhibitors
20070036824 - Optimized expression of hpv 58 l1 in yeast
20070037214 - Generation and selection of protein library in silico
20070037217 - Structure-based selection and affinity maturation of antibody library
20070037219 - Rhesus monkey bombesin receptor subtype-3 (brs-3), nucleotides encoding same, and uses thereof
20070037771 - Process for preparing branched ribonucleosides from 1,2-anhydroribofuranose intermediates
20070037784 - Macrocyclic beta-secretase inhibitors for the treatment of alzheimer's disease
20070037829 - 4-cycloakylaminopyrazolo pyrimidine nmda/nr2b antagonists
20070032491 - Combination of a glycine/nmda antagonist and a tachykinin nk-1 receptor antagonist for use in the treatment of neurodegeneration
20070032517 - Substituted naphthyridinone derivatives
20070032553 - Use of gabaa receptor agonists for the treatment of hearing, vestibular and attention disorders, intention tremor and restless leg syndrome
20070026477 - Whole cell assay involving cathepsin s
20070027071 - Hcv ns3 protease inhibitors
20070027171 - Cycloalkanepyrrolopyridines as dp receptor antagonists
20070027177 - Isoquinolinone potassium channel inhibitors
20070027188 - Ophthalmic compositions for treating ocular hypertension
20070027321 - Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5
January 2007 - Merck And Co., Inc patents
20070021350 - Conjugates useful in the treatment of prostate cancer
20070021430 - Novel crystalline form of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor
20070021442 - Hiv reverse transcriptase inhibitors
20070021453 - Novel spirochromanone derivatives
20070021454 - Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
20070021477 - Cyclohexylglycine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
20070015234 - Whole cell assay for inhibitors of cathepsin k
20070015792 - N-dihydroxyalkyl-substituted 2-oxo-imidazole derivatives
20070015923 - Process for making hydroisoindoline tachykinin receptor antagonists
20070009979 - Cyclic gmp dependent protein kinase as a chemotherapeutic target for antiprotozoal agents
20070009989 - Synthetic heparanase molecules and uses thereof
20070010442 - Inhibitor of vascular endothelial cell growth factor
20070010491 - Ophthalmic compositions for treating ocular hypertension
20070010655 - Stationary phases and a purification process using the stationary phases
20070011757 - Transgenic rodents as animal models for modulation of b1 bradykinin receptor protein
20070004669 - Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
20070004681 - Methods for treating arthritic conditions
20070004714 - Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity
December 2006 - Merck And Co., Inc patents
20060293299 - Substituted 3-alkyl and 3-alkenyl azetidine derivatives
20060293303 - Antiprotozoal imidazopyridine compounds
20060293339 - Biaryl substituted 6-membered heterocycles as sodium channel blockers
20060293358 - Tyrosine kinase inhibitors
20060293364 - Niacin receptor agonists, compositions containing such compounds and methods of treatment
20060293373 - Gamma-secretase inhibitors
20060293380 - Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
20060286114 - Synthetic gene encoding rhesus monkey carcinoembryonic antigen and uses thereof
20060286624 - Method for identifying selective growth inhibitors
20060287302 - Mitotic kinesin inhibitors
20060287326 - 17-acetamido-4-azasteroid derivatives as androgen receptor modulators
20060287340 - 2-aminoquinoline derivatives
20060287348 - 17-acetamido-4-azasteroid derivatives as androgen receptor modulators
20060287349 - 17-heterocyclic-4-azasteroid derivatives as androgen receptor modulators
20060287373 - Cathepsin cysteine protease inhibitors
20060287394 - Composition and method for treating macular disorders
20060287402 - Cathepsin inhibitors
20060287528 - Novel crystalline forms of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor
20060281073 - Broadening adenovirus tropism
20060281181 - Adaptor-directed helper systems
20060281727 - Fused phenylalanine derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
20060281737 - Cyclohexyl sulphones as gamma-secreatase inhibitors
20060281743 - Isoquinolinone potassium channel inhibitors
20060281761 - 4-azasteroid derivatives as androgen receptor modulators
20060281796 - Fused indoles as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
20060281803 - Pyrazole modulators of metabotropic glutamate receptors
20060275761 - Tryptophan hydroxylase assay
20060275835 - Methods for identifying cell surface receptor protein modulators
20060276450 - Isoquinoline potassium channel inhibitors
20060276504 - Ophthalmic compositions for treating ocular hypertension
20060276514 - Tyrosine kinase inhibitors
20060276655 - Cyclohexanesulfonyl derivatives as glyt1 inhibitors to treat schizophrenia
November 2006 - Merck And Co., Inc patents
20060270650 - Combination therapy for the treatment of obesity
20060270673 - Inhibitors of akt activity
20060270679 - Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
20060270704 - Isoquinolinone potassium channel inhibitors
20060270721 - Ep4 receptor agonist, compositions and methods thereof
20060270722 - Combination of a dipeptidyl peptidase-iv inhibitor and a dual ppar agonist for the treatment of diabetes and obesity
20060270841 - Assays to monitor amyloid precursor protein processing
20060264389 - Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
20060264390 - Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
20060264416 - Phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease
20060264474 - Pyrazole derivatives as gamma-secretase inhibitors useful in the treatment of alzheimer's disease
20060257944 - System and method for automated selection of t-cell epitopes
20060258646 - 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
20060258661 - 17-acetamido-4-azasteroid derivatives as androgen receptor modulators
20060258668 - Use of phosphatase inhibitors as adjunct therapy for psychiatric disorders
20060258695 - Triazole derivatives as inhibitors of 11-beta hydroxysteroid dehydrogenase-1
20060258701 - Novel 2-pyridinecarboxamide derivatives
20060258726 - 1,5-disubstituted imidazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of eye and bone diseases
20060258840 - Peroxisome proliferator-activated receptor
20060258860 - N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase
20060252741 - 3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as s1p receptor agonists
20060252937 - Process for making fluorinated 4-azasteroid derivatives
20060246048 - Gene responsible for stargardt-like dominant macular dystrophy
20060247229 - Sulfonyl substituted n-(biarylmethyl) aminocyclopropanecarboxamides
20060247319 - Preparation of 4-bromotetrahydrofluoreneones
October 2006 - Merck And Co., Inc patents
20060239969 - Rhesus her2/neu, nucleotides encoding same, and uses thereof
20060240040 - Optimized expression of hpv 45 l1 in yeast
20060241107 - Androgen receptor modulators and methods of use thereof
20060241133 - Electrically variable pneumatic structural element
20060241299 - Process for making spirolactone compounds
20060233843 - Treatment of psychosis with a muscarinic m1 receptor ectopic activator
20060234962 - Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
20060234984 - Mitotic kinesin inhibitors
20060235021 - Phenylpyridazine derivatives as ligands for gaba receptors
20060235069 - Benzamide modulators of metabotropic glutamate receptors
20060226666 - Autoclavable vacuum lifter
20060228335 - Rhesus carcino embryonic antigen, nucleotides encoding same, and uses thereof
20060228410 - Flavored taste-masked pharmaceutical formulation made using a one-step coating process
20060228697 - Method to confer cell culture replication activity to different hepatitis c virus isolates
20060229264 - Crystalline 6-n-pyridylmethylaminoindolocarbazole compounds
20060229307 - Substituted-1-phthalazinamines as vr-1 antagonists
20060223123 - Rhesus monkey nur77
20060223844 - Mitotic kinesin inhibitors
20060223850 - 8-(3-biaryl)phenylquinoline phosphodiesterase-4 inhibitors
September 2006 - Merck And Co., Inc patents
20060211677 - Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use
20060211682 - Hexahydrodiazepinones as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
20060211687 - Potassium salt of an hiv integrase inhibitor
20060211712 - Bicyclic anilide spirohydantoin cgrp receptor antagonists
20060211722 - Amino cyclobutylamide modulators of chemokine receptor activity
20060211735 - 4-arylsulphonylpiperidine derivatives for antagonism of the 5-ht2a receptor
20060205686 - Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
20060205750 - Novel benzimidazole derivatives
20060205761 - Ccr-2 antagonists for treatment of neuropathic pain
20060205765 - Inhibitors of akt activity
20060205783 - Tetrahydropyran heterocyclic cyclopentyl heteroaryl modulators of chemokine receptor activity
20060198788 - Method of evaluating compound efficacious in treating obesity by using slc25a10
20060199958 - Process and intermediates for the preparation of pyrrolidine carboxylic acids
###
This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Merck And Co., Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Merck And Co., Inc with additional patents listed. Browse our Agent directory for other possible listings.
###
FreshPatents.com Support
|
REGISTER now for FREE 
